Susceptibility testing to second-line drugs and ethambutol by Genotype MTBDRsl and Bactec MGIT 960 comparing with agar proportion method

Tuberculosis

Volumn 92, Issue 5, 2012, Pages 417-421

  Lopez Roa P ^a,b   Ruiz Serrano, M J ^a,b,c   Alcala L ^a,b   Garcia Escribano Raez N ^a,b   Garcia De Viedma D ^a,b,c   Bouza, E ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Genotyp MTBDRsl; MGIT 960; Rapid drug susceptibility testing; Second line drugs

Indexed keywords

AMIKACIN; BACTERIAL DNA; ETHAMBUTOL; OFLOXACIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; GENOTYPE; IN VITRO STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGAR; ANTITUBERCULAR AGENTS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; ETHAMBUTOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; REAGENT STRIPS; RNA, BACTERIAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865499029     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.05.005     Document Type: Article

References (19)

1. E. Nathanson, C. Lambregts-van Weezenbeek, M.L. Rich, R. Gupta, J. Bayona, K. Blondal, J.A. Caminero, J.P. Cegielski, M. Danilovits, M.A. Espinal, V. Hollo, E. Jaramillo, V. Leimane, C.D. Mitnick, J.S. Mukherjee, P. Nunn, A. Pasechnikov, T. Tupasi, C. Wells, and M.C. Raviglione Multidrug-resistant tuberculosis management in resource-limited settings Emerg Infect Dis 12 2006 1389 1397 (Pubitemid 44455215)
2. D. Falzon, E. Jaramillo, H.J. Schunemann, M. Arentz, M. Bauer, J. Bayona, L. Blanc, J.A. Caminero, C.L. Daley, C. Duncombe, C. Fitzpatrick, A. Gebhard, H. Getahun, M. Henkens, T.H. Holtz, J. Keravec, S. Keshavjee, A.J. Khan, R. Kulier, V. Leimane, C. Lienhardt, C. Lu, A. Mariandyshev, G.B. Migliori, F. Mirzayev, C.D. Mitnick, P. Nunn, G. Nwagboniwe, O. Oxlade, D. Palmero, P. Pavlinac, M.I. Quelapio, M.C. Raviglione, M.L. Rich, S. Royce, S. Rusch-Gerdes, A. Salakaia, R. Sarin, D. Sculier, F. Varaine, M. Vitoria, J.L. Walson, F. Wares, K. Weyer, R.A. White, and M. Zignol WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Eur Respir J 38 2011 516 528 10.1183/09031936.00073611
3. WHO global tuberculosis control report 2010. Summary Cent Eur J Public Health 18 2010 237
4. S. Ahmad, and E. Mokaddas Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis Respir Med 103 2009 1777 1790
5. D. Hillemann, S. Rusch-Gerdes, and E. Richter Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens J Clin Microbiol 47 2009 1767 1772
6. F. Bwanga, S. Hoffner, M. Haile, and M.L. Joloba Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis BMC Infect Dis 9 2009 67
7. M. Sharma, L. Thibert, P. Chedore, C. Shandro, F. Jamieson, G. Tyrrell, S. Christianson, H. Soualhine, and J. Wolfe Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis J Clin Microbiol 49 2011 4112 4116 10.1128/jcm.05195-11
8. S. Rusch-Gerdes, G.E. Pfyffer, M. Casal, M. Chadwick, and S. Siddiqi Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials J Clin Microbiol 44 2006 688 692 10.1128/jcm.44.3.688- 692.2006
9. F. Brossier, N. Veziris, A. Aubry, V. Jarlier, and W. Sougakoff Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates J Clin Microbiol 48 2010 1683 1689
10. J. van Ingen, S. Simons, R. de Zwaan, T. van der Laan, M. Kamst-van Agterveld, M.J. Boeree, and D. van Soolingen Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates J Clin Microbiol 48 2010 2749 2753
11. A. Lacoma, N. Garcia-Sierra, C. Prat, J. Maldonado, J. Ruiz-Manzano, L. Haba, P. Gavin, S. Samper, V. Ausina, and J. Dominguez GenoType MTBDRsl for molecular detection of second-line and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples J Clin Microbiol 50 1 2012 Jan 30 36 10.1128/jcm
12. P. Bemer, F. Palicova, S. Rusch-Gerdes, H.B. Drugeon, and G.E. Pfyffer Multicenter evaluation of fully automated BACTEC mycobacteria growth indicator tube 960 system for susceptibility testing of Mycobacterium tuberculosis J Clin Microbiol 40 2002 150 154 (Pubitemid 34027617)
13. S.J. Kim Drug-susceptibility testing in tuberculosis: methods and reliability of results Eur Respir J 25 2005 564 569 10.1183/09031936.05.00111304 (Pubitemid 40331189)
14. S.Y. Lin, E. Desmond, D. Bonato, W. Gross, and S. Siddiqi Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex J Clin Microbiol 47 2009 3630 3634
15. A. Kruuner, M.D. Yates, and F.A. Drobniewski Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis J Clin Microbiol 44 2006 811 818
16. O.V. Antonova, D.A. Gryadunov, S.A. Lapa, A.V. Kuz'min, E.E. Larionova, T.G. Smirnova, E.Y. Nosova, O.I. Skotnikova, L.N. Chernousova, A.M. Moroz, A.S. Zasedatelev, and V.M. Mikhailovich Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips Bull Exp Biol Med 145 2008 108 113
17. H.R. van Doorn, D.D. An, M.D. de Jong, N.T. Lan, D.V. Hoa, H.T. Quy, N.V. Chau, P.M. Duy, D.Q. Tho, N.T. Chinh, J.J. Farrar, and M. Caws Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR Int J Tuberc Lung Dis 12 2008 736 742 (Pubitemid 351976702)
18. I. Mokrousov, T. Otten, O. Manicheva, Y. Potapova, B. Vishnevsky, O. Narvskaya, and N. Rastogi Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia Antimicrob Agents Chemother 52 2008 2937 2939
19. V.S. Kiet, N.T. Lan, D.D. An, N.H. Dung, D.V. Hoa, N. van Vinh Chau, N.T. Chinh, J. Farrar, and M. Caws Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis J Clin Microbiol 48 2010 2934 2939 10.1128/jcm.00201-10